AYTU BIOPHARMA, INC Cash And Cash Equivalents At Carrying Value

Quick Answer

AYTU BIOPHARMA, INC reported Cash And Cash Equivalents At Carrying Value of $30.95 million for the year ending 2025.

  • AYTU BIOPHARMA, INC showed an increase of +54.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from AYTU BIOPHARMA, INC's annual report (Form 10-K), filed with the SEC on September 23, 2025.
  • XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 13 years of available data (2013 to 2025), AYTU BIOPHARMA, INC's Cash And Cash Equivalents At Carrying Value has grown by 962.3%.
  • Historical annual values: Fiscal year 2025: $30.95 million | Fiscal year 2024: $20.01 million | Fiscal year 2023: $22.99 million | Fiscal year 2022: $19.36 million | Fiscal year 2021: $49.65 million | Fiscal year 2020: $48.08 million | Fiscal year 2019: $11.04 million | Fiscal year 2018: $7.01 million | Fiscal year 2017: $802.3 thousand | Fiscal year 2016: $8.05 million | Fiscal year 2015: $7.35 million | Fiscal year 2014: $2.64 million | Fiscal year 2013: $2.91 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: